An NS 3 protease inhibitor with antiviral effects in humans infected with hepatitis C virus

@inproceedings{Lamarre2003AnN3,
  title={An NS 3 protease inhibitor with antiviral effects in humans infected with hepatitis C virus},
  author={Daniel Lamarre and Paul Christopher Anderson and Murray Bailey and Philippe-Olivier Beaulieu and George W. Bolger and Pierre G. Bonneau and Michael Boes and Dale R. Cameron and Mireille Cartier and Michael Graham Cordingley and A. Faucher and Nathalie Goudreau and Stephen H. Kawai and George Kukolj and Lisette Lagac{\'e} and Steven R LaPlante and Hans Narjes and M. Poupart and Jean Rancourt and Roel E. Sentjens and Roger St George and Bruno Simoneau and Gerhard G. Steinmann and Diane Thibeault and Youla S Tsantrizos and Steven M. Weldon and Chan-Loi Yong and Montse Llin{\`a}s-Brunet},
  year={2003}
}
F. D. Rodriguez, G. Resch and M. Ilijin-Jug for technical assistance and plant cultivation; E. Jokitalo for TEM; M. Laxell and S. Tähtiharju for material; I. Bancroft and K. van de Sande at GARNet/GeTCID; N. Sauer for the AtSUC2::GFP line; E. Mellerowicz, F. Rook and M. Saarma for advice; and P. N. Benfey, B. Scheres and C. Alonso Blanco for comments on the manuscript. Financial support was provided by the Academy of Finland, Tekes, EU, EMBO and the University of Helsinki. 

Figures and Tables from this paper.

Citations

Publications citing this paper.
SHOWING 1-10 OF 75 CITATIONS, ESTIMATED 39% COVERAGE

Replicon cell culture system as a valuable tool in antiviral drug discovery against hepatitis C virus.

  • Antiviral chemistry & chemotherapy
  • 2005
VIEW 3 EXCERPTS
CITES METHODS & BACKGROUND
HIGHLY INFLUENCED

HCV genetics and genotypes dictate future antiviral strategies.

  • Journal of molecular biochemistry
  • 2017
VIEW 1 EXCERPT
CITES BACKGROUND

FILTER CITATIONS BY YEAR

2004
2019

CITATION STATISTICS

  • 2 Highly Influenced Citations

References

Publications referenced by this paper.
SHOWING 1-10 OF 35 REFERENCES

Macrocyclic peptides active against the Hepatitis C virus

  • US patent 6,608,027
  • 2003

Regulation of interferon regulatory factor-3 by the hepatitis C virus serine protease

E Foy
  • Science 300,
  • 2003

First report on the antiviral efficacy of BILN 2061 , a novel oral serine protease inhibitor , in patients with chronic hepatitis C genotype 1

Y. Benhamou
  • Hepatology
  • 2002

First report on the antiviral efficacy of BILN 2061, a novel oral serine protease inhibitor, in patients with chronic hepatitis C genotype 1. Hepatology 36, 297A, Abst

H Hinrichsen
  • 2002

Tolerability and pharmacokinetics of BILN 2061 : a novel serine protease HCV inhibitor after oral single doses of 5 mg to 2 , 400 mg in healthy male subjects

H. Hinrichsen
  • Hepatology
  • 2002

Treatment of chronic hepatitis C : a systematic review

G. Chander
  • Hepatology
  • 2002